...
首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >Risk factors, fractures, and management of pregnancy-associated osteoporosis: a retrospective study of 14 Turkish patients
【24h】

Risk factors, fractures, and management of pregnancy-associated osteoporosis: a retrospective study of 14 Turkish patients

机译:妊娠相关骨质疏松症的危险因素,骨折和管理:14例土耳其患者的回顾性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Pregnancy-associated osteoporosis (PAO) is a rare but painful disease. The current study aimed to investigate the demographic and clinical features, risk factors, treatment options, and outcomes of Turkish patients with PAO. In our retrospective, cross-sectional, and descriptive study the time to PAO diagnosis was 3.6 months. Pain and loss of height were detected in 78.6% and 28.6% of patients, respectively. As such, 60.6% of patients reported fractures at the thoracic area, 30.3% at the lumbar area, and 9.1% at the sacral area. While 14.3% of patients had optimal vitamin D status during pregnancy, 64.3% had vitamin D deficiency, and 21.4% had vitamin D insufficiency. Of the patients, 21.4% received anticoagulant therapy during their pregnancy. Dual X-ray absorptiometry scans revealed that osteoporosis was predominantly in the trabecular bone (L1-L4 Z-score -2.9, Femur Z score -2.19). Management options included supplements of calcium with vitamin D (93%), weaning the baby (79%), specific treatments for osteoporosis (64%), use of a supportive corset (50%), and exercise (21%), respectively. In addition, after delivery, 35.7% of patients were administered denosumab, 21.4% bisphosphonate, and 7.1% were given teriparatide. Data of the clinical features, treatments, and outcomes of PAO may contribute to early detection and management.
机译:妊娠相关骨质疏松症(PAO)是一种罕见但痛苦的疾病。目前的研究旨在调查土耳其患者的人口统计学和临床​​特征,危险因素,治疗方案和去除患者的PAO患者的结果。在我们的回顾性,横断面和描述性研究中,PAO诊断的时间为3.6个月。 78.6%和28.6%的患者分别检测到高度疼痛和损失。因此,60.6%的患者报告了胸部区域的骨折,腰部区域30.3%,骶骨区域9.1%。虽然14.3%的患者在怀孕期间具有最佳的维生素D状态,但64.3%的维生素D缺乏症,21.4%具有维生素D功能不全。在患者的患者中,21.4%在怀孕期间接受抗凝血治疗。双X射线吸收测量扫描显示,骨质疏松症主要在小梁骨中(L1-L4 Z-Score -2.9,股骨Z得分-2.19)。管理选择包括钙的补充剂,维生素D(93%),婴儿断奶(79%),骨质疏松症的特定治疗(64%),分别使用支撑紧身胸衣(50%)和运动(21%)。此外,在递送后,35.7%的患者被施用Denosumab,21.4%双膦酸盐,7.1%得到萜状水。 PAO的临床特征,治疗和结果的数据可能有助于早期检测和管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号